Company Overview - Xinkai Technology is a professional supplier of colorants, primarily engaged in the development, sales, and service of organic pigments and other colorants [1][2] - The company focuses on product development, quality management, supply chain integration, and global sales network layout as its core competitive advantages [1] IPO Details - Xinkai Technology plans to raise approximately 26.46 million yuan for the construction of a research and development center and headquarters, as well as to repay bank loans [2] - The company is set to issue shares at a price of 12.80 yuan per share, with an expected total fundraising amount of approximately 29.99 million yuan, after deducting issuance costs of about 5.61 million yuan [2] Shareholding Structure - Xinkai Technology's controlling shareholder is Xinkai Senyuan, which directly holds 56.90% of the company's shares [2] - The actual controllers, Li Zhi and Li Wu, collectively control 97% of the company through direct and indirect holdings [2] Industry Context - The reference industry for Xinkai Technology's price-earnings ratio is wholesale, with a current industry average P/E ratio of 20.61 compared to the company's P/E ratio of 14.38 [1]

Core Viewpoint - The listing of Taihe Co., Ltd. (301665.SZ) on the ChiNext board marks a significant event, as the company is a leader in the pesticide and functional chemicals industry, with a strong position in key products such as Bacillus subtilis, pyraclostrobin, and 2,4-D [1][2]. Group 1: Company Overview - Taihe Co., Ltd. specializes in the research, production, and sales of pesticide products and functional chemicals, holding a leading position in the industry in terms of production scale and comprehensive technology level [1]. - The company has established long-term strategic partnerships with multinational corporations such as Syngenta, Dow, and Honeywell, expanding its market reach to regions including South America, North America, Southeast Asia, and Europe [3]. Group 2: Financial Metrics - The initial public offering (IPO) price was set at 10.27 CNY per share, with an institutional offering price of 10.68 CNY per share, resulting in a market capitalization of 46.22 billion CNY [2]. - The company’s earnings report indicates a significant growth trajectory, with a projected revenue increase of 60% [2]. - The company’s issuance price corresponds to a price-to-earnings (P/E) ratio of 13.40, compared to the industry average P/E ratio of 23.01 [2]. Group 3: Fund Utilization - The company plans to allocate 8.96 billion CNY (85.76%) of the raised funds towards a fungicide project and 1.49 billion CNY (14.24%) towards a research and development center project [2]. Group 4: Export Performance - From 2021 to 2024, the company’s overseas sales revenue was 28.01 billion CNY, 45.49 billion CNY, 29.46 billion CNY, and 14.54 billion CNY, representing 78.42%, 89.58%, 77.10%, and 74.43% of total operating income, respectively [3].

Core Insights - The chairman of Taihe Co., Tian Xiaohong, emphasizes the importance of the pesticide industry for food security and agricultural productivity, highlighting the need for safe and environmentally friendly agricultural chemicals [2][3][4] - Taihe Co. has transitioned from merely trading pesticides to integrating research, production, and technology, aiming to innovate and compete with global agricultural giants [3][4] - The company has developed key products such as Bacillus amyloliquefaciens, 2,4-D, and pyraclostrobin, which are significant in the global market, with Bacillus amyloliquefaciens holding a 60% market share [6][7] Industry Context - The global population growth poses challenges for food security, with the need for increased agricultural productivity being critical, where pesticides play a vital role [3][4] - China produces 70% to 80% of the world's pesticides but still lags behind major global players in high-end agricultural products [3][4] - The pesticide industry is currently facing overcapacity and a "micro-profit era," prompting companies like Taihe to innovate and adapt to maintain competitiveness [8] Company Strategy - Taihe Co. has focused on R&D, with over 3% of its revenue allocated to innovation since 2021, resulting in 363 patents, including 73 overseas [8][9] - The company plans to use funds from its IPO to enhance its core product line of fungicides and develop a complete product line [8][9] - Future investments will target the construction of new production capacities for green pesticides, aligning with international agricultural trends [9][10]

证券代码：002215 证券简称：诺普信 公告编号：2025-004 特此公告。 深圳诺普信作物科学股份有限公司董事会 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）参股公司南通泰禾化工股份有限公司（以下简 称"泰禾股份"）于2025年4月11日在深圳证券交易所创业板上市，股票简称：泰禾股份，股票代码： 301665，发行价格为10.27元/股，具体内容详见泰禾股份在深圳证券交易所网站（http://www.szse.cn/） 公告的《首次公开发行股票并在创业板上市之上市公告书》。 截至本公告披露日，公司持有泰禾股份1,778万股，占其首次公开发行前总股本的4.39%，占其发行后总 股本的3.95%。公司持有的泰禾股份前述股份自其上市之日起12个月内不得转让。 根据企业会计准则相关规定，公司持有的泰禾股份股权作为"以公允价值计量且其变动计入其他综合收 益的金融资产"核算，并列报在"其他权益工具投资"中。泰禾股份上市后，公司对其会计核算方法不会 发生改变，其股价波动对公司当期损益不会产生影响。请广大投资者理性投资，注意 ...

Core Viewpoint - Taihe Co., Ltd. officially listed on the Shenzhen Stock Exchange's Growth Enterprise Market on April 11, 2023, and aims to become a leading player in the agricultural chemical industry by focusing on product excellence and innovation [1][2]. Group 1: Company Overview - Taihe Co., Ltd. transitioned from an import-export trading company to a manufacturer, emphasizing technology and research and development as key components of its international growth strategy [2][3]. - The company has established long-term strategic partnerships with multinational corporations such as Syngenta, Dow, and UPL, with exports covering major global markets including South America, North America, Southeast Asia, and Europe [2][3]. Group 2: Core Products and Technologies - Taihe Co., Ltd. holds a leading position in three core products: Bacillus subtilis, Pyraclostrobin, and 2,4-D, with an average annual capacity utilization rate exceeding 100% from 2021 to 2023 [4]. - The company has mastered key technologies such as ammonia oxidation, chlorination, hydrogenation, and fluorination, which support its industry-leading status in core products [4]. Group 3: Innovation and Environmental Focus - The company is committed to integrating innovative technology into its products to promote greener and more efficient agricultural practices, aligning with national low-carbon development goals [5]. - Taihe Co., Ltd. has made significant advancements in the production process of 2,4-D, eliminating unpleasant odors and enhancing environmental friendliness, which has improved product acceptance [7]. Group 4: Market Position and Strategy - In a challenging market environment characterized by price wars, Taihe Co., Ltd. has maintained a profit margin of 5%, above the industry average of 3%, by leveraging technological and managerial efficiencies [8]. - The company is transitioning from a "boss strategy" to a "team strategy," restructuring its operations into three business units: plant protection, functional chemicals, and new energy materials [9]. Group 5: Future Prospects - Taihe Co., Ltd. is focused on the development of new pesticides, with a promising product, cyclopropyl fluorochloride, expected to enter the global market by mid-2024 [11]. - The company aims to expand its business scope and industry position significantly through the commercialization of innovative products, potentially becoming the first Chinese company to achieve global sales of a new compound [11].

来源|贝多财经 "泰禾"二字重现在A股市场。 4月9日，南通泰禾化工股份有限公司（SZ:301665，下称"泰禾股份"）披露《首次公开发行股票并在创业板上市之上市公告书》称，该公司将于2025年4月11 日在深圳证券交易所创业板上市，证券简称为"泰禾股份"。 天眼查App信息显示，泰禾股份成立于2004年4月，位于江苏省南通市。目前，该公司的注册资本为4.05亿元，法定代表人为田晓宏，主要股东包括泰禾集 团、上海鋆麟企业管理咨询有限公司等。 | | | | 家庭的副人 | 中国等通 | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 春天集团有限公司 | | 上海省颜企业管理咨 询有限公司 | 提现语量信作题科学 股份有限公司 | 杭州恒丰君南投资合 伏企业 [有限合_ | 上海藏领企业管理资 海有限公司 | 中国保险投资基金 ( 有限合伙] | | 中国农业产业发展基 全有限公司 | 假和海 ...

南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市之 上市公告书提示性公告 保荐人（主承销商）：光大证券股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 经深圳证券交易所审核同意，南通泰禾化工股份有限公司（以下简称"公司"、 "本公司"、"发行人"或"泰禾股份"）发行的人民币普通股股票将于 2025 年 4 月 11 日在深圳证券交易所创业板上市，上市公告书全文和首次公开发行股票并在 创业板上市招股说明书全文披露于中国证券监督管理委员会指定信息披露网站 （巨潮资讯网，网址 www.cninfo.com.cn；中证网，网址 www.cs.com.cn；中国证 券网，网址 www.cnstock.com；证券时报网，网址 www.stcn.com；证券日报网， 网址 www.zqrb.cn）。 所属网页二维码：巨潮资讯网 一、上市概况 （三）首次公开发行后的总股本：45,000.0000 万股 （四）首次公开发行的股票数量：4,500.0000 万股，全部为公开发行的新股， 无老股转让 二、风险提示 本公司股票将在深圳证券交易所创业板市场上市，该 ...

股票简称：泰禾股份 股票代码：301665 南通泰禾化工股份有限公司 CAC Nantong Chemical Co., Ltd. （江苏省如东县洋口化学工业园区） 首次公开发行股票并在创业板上市 之 上市公告书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 二〇二五年四月 南通泰禾化工股份有限公司 上市公告书 特别提示 南通泰禾化工股份有限公司（以下简称"泰禾股份"、"发行人"、"公司"、 "本公司"）股票将于 2025 年 4 月 11 日在深圳证券交易所创业板上市。 创业板公司具有业绩不稳定、经营风险高、退市风险高等特点，投资者面 临较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露 的风险因素，审慎做出投资决定。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在 新股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 本上市公告书"报告期"指：2021 年度、2022 年度、2023 年度及 2024 年 1-6 月。 本上市公告书中若出现总数与各分项数值之和尾数不符的情况，均为四舍 五入所致。 1 南通泰禾化工股份有限公司 上市公告书 第一节 重要声明 ...

北京市天元律师事务所 关于南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市的 法律意见书 北京市天元律师事务所 关于南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市的 法律意见书 京天股字（2020）第 472-64 号 致：南通泰禾化工股份有限公司 根据北京市天元律师事务所（以下简称"本所"）与南通泰禾化工股份有限公 司（以下简称"发行人"或"公司"）签订的法律服务协议，本所担任公司本次首次 公开发行股票并在创业板上市的专项法律顾问，并为发行人本次发行上市出具了 京天股字（2020）第 472 号《北京市天元律师事务所关于南通泰禾化工股份有限 公司首次公开发行股票并在创业板上市的法律意见书》、京天股字（2020）第 472-1 号《北京市天元律师事务所关于南通泰禾化工股份有限公司首次公开发行 股票并在创业板上市的律师工作报告》、京天股字（2020）第 472-5 号《北京市 天元律师事务所关于南通泰禾化工股份有限公司首次公开发行股票并在创业板 上市的补充法律意见书（一）》、京天股字（2020）第 472-8 号《北京市天元律 师事务所关于南通泰禾化工股份有限公司首次公开发行股票并在创业板上市 ...

光大证券股份有限公司 关于 南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市 之 上市保荐书 保荐机构 二〇二五年四月 南通泰禾化工股份有限公司 上市保荐书 深圳证券交易所： 南通泰禾化工股份有限公司（以下简称"南通泰禾"、"发行人"、"公 司"）申请首次公开发行股票并在创业板上市，发行人本次发行股票总数为 4,500 万股，全部为公开发行新股。光大证券股份有限公司（以下简称"光大证券"、 "保荐机构"、"本保荐机构"）认为发行人申请首次公开发行股票并在创业板 上市完全符合《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《首次公开发行股票注册管 理办法》（以下简称"《首发注册管理办法》"）、《深圳证券交易所创业板股 票上市规则》的有关规定，特推荐其股票在贵所创业板上市交易。 如无特别说明，本上市保荐书中的简称或名词的释义与《南通泰禾化工股份 有限公司首次公开发行股票并在创业板上市招股说明书》中相同。 1 南通泰禾化工股份有限公司 上市保荐书 保荐机构及保荐代表人声明 光大证券股份有限公司及具体负责本次证券发行项目的保荐代表人杜攀明、 刘铁波已根 ...